483
Bristol-Myers Squibb CompanyBristol-Myers Squibb Company – FDA 483, May 5, 2023
Record Details
Bristol Myers Squibb (BMS) in Devens, Massachusetts, a drug product manufacturer, was issued a Form 483 following an FDA inspection. The inspection revealed a significant deficiency in the firm's quality system, specifically its failure to fully investigate manufacturing deviations and component failures. This included 337 "no impact" deviations that lacked root cause investigations and appropriate corrective and preventative actions.
View Company Profile
ID · a7910c72-02d4-4e79-b454-32680a26de2f
Other documents for Bristol-Myers Squibb Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.